Long-acting lenacapavir acts as an effective preexposure prophylaxis in a rectal SHIV challenge macaque model
Journal of Clinical Investigation · 15.08.2023 · 133 (16)
DOI: 10.1172/jci167818 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Clinical Investigation, online erschienen am 15.08.2023. Verfasst von Elena Bekerman und 7 weiteren Autor:innen. Hauptthemen laut MEDLINE: Simian Acquired Immunodeficiency Syndrome, Simian Immunodeficiency Virus, Anti-HIV Agents, HIV Infections. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Gilead Sciences.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Förderung
- Gilead Sciences
Zitieren
APA
Bekerman, E., Yant, S. R., VanderVeen, L., Hansen, D., Lu, B., Rowe, W., Wang, K., & Callebaut, C. (2023). Long-acting lenacapavir acts as an effective preexposure prophylaxis in a rectal SHIV challenge macaque model. Journal of Clinical Investigation, 133(16). https://doi.org/10.1172/jci167818
Vancouver
Bekerman E, Yant SR, VanderVeen L, Hansen D, Lu B, Rowe W, et al. Long-acting lenacapavir acts as an effective preexposure prophylaxis in a rectal SHIV challenge macaque model. Journal of Clinical Investigation. 2023;133(16). doi:10.1172/jci167818
BibTeX
@article{Bekerman2023,
author = {Bekerman, Elena and Yant, Stephen R and VanderVeen, Laurie and Hansen, Derek and Lu, Bing and Rowe, William and Wang, Kelly and Callebaut, Christian},
title = {Long-acting lenacapavir acts as an effective preexposure prophylaxis in a rectal SHIV challenge macaque model},
journal = {Journal of Clinical Investigation},
year = {2023},
volume = {133},
number = {16},
doi = {10.1172/jci167818}
}
EUVIMED